ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
(Q47748338)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1074/JBC.M403240200
|
(P698) |
15090553
|
(P8608) |
release_hvjmmi24hnajfc6v4mhy54l6ny
|